Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in bruch's membrane of the aging eye

Molecular Vision

Volumn 5, Issue 11, 1999, Pages

  Farboud, Behnom ^a   Aotaki Keen, Amy ^a   Miyata, Toshio ^b   Hjelmeland, Leonard M ^a,c   Handa, James T ^a,d  

^a Departments of Ophthalmology   (United States)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ADVANCED GLYCATION END PRODUCT; ANTIBODY; ARGININE; DRUG DERIVATIVE; GLYCOLALDEHYDE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE; PENTOSIDINE; SCLEROPROTEIN;

ADULT; AGED; AGING; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BRUCH MEMBRANE; CATTLE; CHOROID PLEXUS; COMPARATIVE STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFANT; METABOLISM; MIDDLE AGED;

ACETALDEHYDE; ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; ARGININE; BRUCH MEMBRANE; CATTLE; CHOROID PLEXUS; EXTRACELLULAR MATRIX PROTEINS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LYSINE; MIDDLE AGED;

EID: 0033553936     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318:1315-21.
2. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40:405-12.
3. Monnier VM, Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981; 211:491-3.
4. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A 1994; 91:4766-70.
5. Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med 1996; 28:419-26.
6. Matsumoto K, Ikeda K, Horiuchi S, Zhao H, Abraham EC. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses. Biochem Biophys Res Commun 1997; 241:352-4.
7. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997; 51:1170-81.
8. Ahmed MU, Thorpe SR, Baynes JW. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986; 261:4889-94.
9. Sell DR, Monnier VM. Structure elucidation of a senescence crosslink from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 1989; 264:21597-602.
10. Handa JT, Verzijl N, Matsunaga H, Aotaki-Keen A, Lutty GA, te Koppele JM, Miyata T, Hjelmeland LM. Increase of the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci 1999; 40:775-9.
11. Ishibashi T, Murata T, Hangai M, Nagai R, Horiuchi S, Lopez PF, Hinton DR, Ryan SJ. Advanced glyation end products in age-related macular degeneration. Arch Ophthalmol 1998; 116:1629-32.
12. Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 1992; 267:5133-8.
13. Nakayama H, Mitsuhashi T, Kuwajima S, Aoki S, Kuroda Y, Itoh T, Nakagawa S. Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes 1993; 42:345-50.
14. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J Biol Chem 1991; 266:7329-32.
15. Nishino T, Horii Y, Shiiki H, Yamamoto H, Makita Z, Bucala R, Dohi K. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy. Hum Pathol 1995; 26:308-13.
16. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995; 34:10872-8.
17. Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C, Maeda K. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996; 7:1198-206.
18. Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM. Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci U S A 1996; 93:2353-8.
19. Ishigooka H, Aotaki-Keen AE, Hjelmeland LM. Subcellular localization of bFGF in human retinal pigment epithelium in vitro. Exp Eye Res 1992; 55:203-14.
20. Dunn JA, McCance DR, Thorpe SR, Lyons TJ, Baynes JW. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 1991; 30:1205-10.
21. Hasegawa G, Nakano K, Tsutsumi Y, Kondo M. Effects of aldehyde-modified proteins on mesangial cell-matrix interaction. Diabetes Res Clin Pract 1994; 23:25-32.
22. Boyd-White J, Williams JC Jr. Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes. Diabetes 1996; 45:348-53.
23. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 1991; 266:11654-60.
24. Glomb MA, Monnier VM. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 1995; 270:10017-26.
25. Takedo A, Yasuda T, Miyata T, Mizuno K, Li M, Yoneyama S, orie K, Maeda K, Sobue G. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci Lett 1996; 221:17-20.
26. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, Monnier VM. Aging of proteins: immunological detection of a glucose-derived pyrrole formed during maillard reaction in vivo. J Biol Chem 1989; 264:3758-64.
27. Ienaga K, Nakamura K, Hochi T, Nakazawa Y, Fukunaga Y, Kakita H, Nakano K. Crosslines, fluorophores in the AGE-related cross-linked proteins. Contrib Nephrol 1995; 112:42-51.
28. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, Strihou CY, Monnier VM, Witztum JL, Kurokawa K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 1997; 100:2995-3004.